NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Update

by · The Cerbat Gem

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 5,200 shares, a growth of 300.0% from the September 30th total of 1,300 shares. Based on an average daily trading volume, of 4,300 shares, the days-to-cover ratio is presently 1.2 days.

NRx Pharmaceuticals Stock Performance

NRXPW stock traded down $0.00 on Friday, reaching $0.05. The company’s stock had a trading volume of 10,779 shares, compared to its average volume of 16,955. NRx Pharmaceuticals has a 52 week low of $0.04 and a 52 week high of $0.39. The firm has a fifty day moving average of $0.06 and a two-hundred day moving average of $0.09.

NRx Pharmaceuticals Company Profile

(Get Free Report)

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.

Further Reading